• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER (ISRAEL) LTD. CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER (ISRAEL) LTD. CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number M-4800-01
Device Problems Entrapment of Device (1212); Unintended Collision (1429); Difficult to Remove (1528)
Patient Problem No Code Available (3191)
Event Date 09/25/2014
Event Type  Injury  
Event Description
It was reported that a patient underwent an atrial fibrillation procedure with a lasso¿ 2515 variable circular mapping catheter and carto® 3 system and the catheter got entangled in mitral valve apparatus.During the procedure, the lasso catheter due to manipulation was entangled in the mitral valve apparatus.In addition, the lasso loop appeared on carto system as if on normal plane while under fluoroscopy, loop was distorted.The patient underwent surgical intervention in order to remove the catheter.The patient was reported to be recovered at the time bwi followed-up with the physician; the patient required hospitalization.The physician¿s opinion regarding the cause of this adverse event is that this is procedure and product related.The physician stated the risks involved in this type of procedure and aware of the guidelines when using the lasso catheter in the la anatomy.The instruction for use (ifu) recommends that a careful catheter manipulation must be performed in order to avoid cardiac damage, perforation, or tamponade.The lasso catheter is not recommended for use in the ventricles.Bwi determined to take a conservative approach and therefore reported carto 3 system, even though there is no sufficient evidence whether our equipment may have contributed to the reported event.
 
Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.Concomitant bwi products: product: thermocool® smart touch¿ bi-directional navigation catheter us catalog # d132705 lot # unknown manufacturer's reference # (b)(4) and (b)(4), are related to the same event d) manufacturer's reference # (b)(4).
 
Manufacturer Narrative
(b)(4).It was reported that a patient underwent an atrial fibrillation procedure with a lasso¿ 2515 variable circular mapping catheter and carto® 3 system and the catheter got entangled in mitral valve apparatus.During the procedure, the lasso catheter due to manipulation was entangled in the mitral valve apparatus.In addition, the lasso loop appeared on carto system as if on normal plane while under fluoroscopy, loop was distorted.The patient underwent surgical intervention in order to remove the catheter.The patient was reported to be recovered at the time bwi followed-up with the physician; the patient required hospitalization.The physician¿s opinion regarding the cause of this adverse event is that this is procedure and product related.The physician stated the risks involved in this type of procedure and aware of the guidelines when using the lasso catheter in the la anatomy.The instruction for use (ifu) recommends that a careful catheter manipulation must be performed in order to avoid cardiac damage, perforation, or tamponade.The lasso catheter is not recommended for use in the ventricles.Bwi determined to take a conservative approach and therefore reported carto 3 system, even though there is no sufficient evidence whether our equipment may have contributed to the reported event.The investigational analysis has been completed.The log files and recordings could not be exported from the system due to regulatory hold following a defect identified in the anonymize feature.Field service engineer (fse) contacted the local team and they confirmed that the system was used for several cases after the event without further issues.The system is working normally.The history of customer complaints associated with carto 3 system # (b)(4) was reviewed.Out of (b)(4) additional reported complaints, no additional complaint that may be related to the reported issue was identified.A device history record review was performed by the manufacturer and no anomalies were noted in manufacturing or servicing of this equipment.The customer complaint was not confirmed.Management is notified of failure analysis through the monthly trending reports.No significant trends have been identified at this time; therefore, no capa activity is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS  2066717
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 2066 717
IS   2066717
Manufacturer Contact
jaime chavez
15715 arrow highway
irwindale, CA 91706
9098398483
MDR Report Key4200712
MDR Text Key5150984
Report Number3008203003-2014-00069
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/26/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM-4800-01
Device Catalogue NumberFG540000
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/25/2014
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age74 YR
Patient Weight70
-
-